ARCHIVES

Brawley: CMS Got it Right in Lung Cancer Screening Decision

This article is from The Cancer Letter archive.

Vol. 40 No. 43 | November 14, 2014

Download PDF Visit The Full Archive

Related Articles

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

President’s Cancer Panel To Meet In Hawaii Nov. 9 On centers; Committee Leans Toward New Cancer Control Cooperative Group

August 24, 1984

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

DCT Programs Status Reported to Board

July 5, 1985

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012